Werewolf Collaborates With Merck On WTX-124 In Combination With KEYTRUDA finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
TORONTO, June 03, 2021 Field Trip Health Ltd. , a leader in the development and delivery of psychedelic therapies, is pleased to announce that its common shares will commence trading on.
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs.
Once again, some insiders have taken .
Possible Member of 10% Group of Werewolf Therapeutics, Inc. (NASDAQ:HOWL), Flynn James E, buys 800,000 shares worth $12,800,000
According to Werewolf Therapeutics, Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated May 04 12:34 PM, company Possible Member of 10% Group, Flynn James E disclosed buying 800,000 shares at a cost of $16.00. At the time of this transaction (May 04), this trade was worth $12,800,000 in total. As of May 04, Flynn James E now owns 2,552,787 shares in total worth about $41,967,818.28.
For the last few recent trades made by Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Possible Member of 10% Group, Flynn James E, we have the following information: